Do immigrants from Turkey, Pakistan and Yugoslavia receive adequate medical treatment with beta-blockers and statins after acute myocardial infarction compared with Danish-born residents? A register-based follow-up study

European Journal of Clinical Pharmacology

Volumn 66, Issue 7, 2010, Pages 735-742

  Hempler, Nana Folmann ^a   Diderichsen, Finn ^b   Larsen, Finn Breinholt ^c   Ladelund, Steen ^a   Jørgensen, Torben ^a  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Centre of Public Health   (Denmark)

Author keywords

Acute myocardial infarction; Beta blockers; Immigrants; Socioeconomic status; Statins

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; DENMARK; DOCTOR PATIENT RELATION; EDUCATION; EMPLOYMENT; ETHNIC DIFFERENCE; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; IMMIGRANT; INCOME; MAJOR CLINICAL STUDY; MALE; PAKISTAN; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; REGISTER; SOCIAL STATUS; TURKEY (REPUBLIC); YUGOSLAVIA; ACUTE DISEASE; ADOLESCENT; COMPARATIVE STUDY; ETHNOLOGY; MEDICATION COMPLIANCE; MIDDLE AGED; MIGRANT; MYOCARDIAL INFARCTION; SOCIAL CLASS; STATISTICAL MODEL; TURKEY;

ACUTE DISEASE; ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; DENMARK; EMIGRANTS AND IMMIGRANTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MODELS, STATISTICAL; MYOCARDIAL INFARCTION; PAKISTAN; SOCIAL CLASS; TURKEY; YUGOSLAVIA;

EID: 77955564187     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-010-0816-3     Document Type: Article

References (25)

1. Statistics Denmark (2009) Indvandrere i Danmark (Immigrants in Denmark). Copenhagen, Statistics Denmark
2. Balarajan R (1991) Ethnic differences in mortality from ischaemic heart disease and cerebrovascular disease in England and Wales. Br Med J 302(6776):560-564
3. Gadd M, Johansson SE, Sundquist J, Wandell P (2005) The trend of cardiovascular disease in immigrants in Sweden. Eur J Epidemiol 20(9):755-760
4. Harding S, Rosato M, Teyhan A (2008) Trends for coronary heart disease and stroke mortality among migrants in England and Wales, 1979-2003: slow declines notable for some groups. Heart 94(4):463-470
5. Wild SH et al (2007) Mortality from all causes and circulatory disease by country of birth in England and Wales 2001-2003. J Public Health 29(2):191-198
6. Folmann NB, Jorgensen T (2006) Etniske minoriteter-sygdom og brug af sundhedsvæsenet (Ethnic minorities-chronic diseases and use of health care services). National Board of Health, Copenhagen
7. Rasmussen JN et al (2007) Use of statins and beta-blockers after acute myocardial infarction according to income and education. J Epidemiol Community Health 61(4):1091-1097
8. Thomsen RW et al (2005) Socioeconomic gradient in use of statins among Danish patients: population-based cross-sectional study. Br J Clin Pharmacol 60(5):534-542
9. Bhopal R et al (2002) Ethnic and socio-economic inequalities in coronary heart disease, diabetes and risk factors in Europeans and South Asians. J Public Health Med 24:95-105
10. Cooper H (2002) Investigating socio-economic explanations for gender and ethnic inequalities in health. Soc Sci Med 54(5):693-706
11. Nazroo JY (2001) South Asian people and heart disease: an assessment of the importance of socioeconomic position. Ethn Dis 11(3):401-411
12. Winkleby MA, Kraemer HC, Ahn DK, Varady AN (1998) Ethnic and socioeconomic differences in cardiovascular disease risk factors: findings for women from the Third National Health and Nutrition Examination Survey, 1988-1994. JAMA 280(4):356-362
13. Christensen B et al (2007) Klinisk vejledning. Forebyggelse af iskæmisk hjerte-kar-sygdom i almen praksis (Clinical Guideline. Prevention of ischaemic heart disease in general practice). Danish College of General Practitioners
14. Collins R, Armitage J, Parish S, Sleigh P, Peto R (2003) MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 361(9374):2005-2016
15. Freemantle N, Cleland J, Young P, Mason J, Harrison J (1999) Beta Blockade after myocardial infarction: systematic review and meta regression analysis. Br Med J 318(7200):1730-1737
16. Andrade SE, Kahler KH, Frech F, Chan KA (2006) Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 15(8):565-574
17. WHO Collaborating Centre for Drug Statistics (2009) Methodology, guidelines for ATC classification and DDD assignment 2010.WHO, Oslo
18. Schouten BC, Meeuwesen L (2006) Cultural differences in medical communication: a review of the literature. Patient Educ Couns 64(1-3):21-34
19. Meeuwesen L et al (2006) Do Dutch doctors communicate differently with immigrant patients that with Dutch patients? Soc Sci Med 63(9):2407-2417
20. Weitoft GR et al (2008) Equal access to treatment? Population-based follow-up of drugs dispensed to patients after acute myocardial infarction in Sweden. Eur J Clin Pharmacol 64:417-424
21. Charles H, Good CB, Hanusa BH, Chang CC, Whittle J (2003) Racial differences in adherence to cardiac medications. J Natl Med Assoc 95(1):17-27
22. Bosworth HB et al (2006) Racial differences in blood pressure control: potential explanatory factors. Am J Med 119(1):70.e9-70.e15
23. Kressin NR et al (2007) Hypertensive patients' race, health beliefs, process of care, and medication adherence. J Gen Intern Med 22 (6):768-774
24. Uiters E et al (2006) Ethnic minorities and prescription medication; concordance between self-reports and medical records. BMC Health Serv Res 6:115
25. Madsen M et al (2003) The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol 56(2):124-130